# PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

> **NCT01320254** · PHASE2 · COMPLETED · sponsor: **Hannover Medical School** · enrollment: 93 (actual)

## Conditions studied

- Cholangiocarcinomas

## Interventions

- **DRUG:** Cisplatin, Gemcitabine, Panitumumab
- **DRUG:** Cisplatin, Gemcitabine

## Key facts

- **NCT ID:** NCT01320254
- **Lead sponsor:** Hannover Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2016-09-12
- **Final completion:** 2016-09-12
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2017-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320254

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320254, "PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01320254. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*